Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of tolerance and effectiveness of an artichoke preparation in patients with chronic hepatitis C
2005-000687-77Phase 2Active
- Sponsor
- Uni-Zentrum Naturheilkunde
- Start
- Apr 2005
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of artichoke leaf extract in hepatitis C virus infection, sponsored by Uni-Zentrum Naturheilkunde. Primary endpoint: Alanine aminotransferase after 12 weeks of therapy. Started Apr 2005; status: active.
02
Drugs
artichoke leaf extract
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2005-000687-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000687-77.